SCREENS for Cancer Act of 2024
Latest Action
Placed on the Union Calendar, Calendar No. 437.
Official Summary
Official summary has not been imported yet.
GovScope Watchdog™
AI Government Intelligence™The SCREENS for Cancer Act of 2024 is a House bill introduced during the 118th Congress aimed at addressing cancer screening. Although the official summary and full text are not available, the bill title and policy area indicate a focus on improving or expanding cancer screening efforts. The bill was placed on the Union Calendar but ultimately failed or expired without further legislative action.
This bill sought to enhance cancer screening initiatives but did not advance beyond being scheduled for consideration and expired without passage.
- The bill is titled SCREENS for Cancer Act of 2024 and relates to health policy, specifically cancer screening.
- It was introduced in the House during the 118th Congress and placed on the Union Calendar (Calendar No. 437).
- No official summary or full text is publicly available, and the bill status is marked as failed or expired.
['Individuals at risk for or concerned about cancer who may gain improved access to screening services if the bill had passed.', 'Healthcare providers and public health agencies involved in cancer screening programs.']
['Lack of publicly available bill text and summary limits understanding of specific provisions and implementation mechanisms.', 'Without passage, no changes to current cancer screening policies or funding would occur.', 'Potential costs, funding sources, and oversight responsibilities are unknown due to missing detailed information.']
The bill was introduced in the House during the 118th Congress and was placed on the Union Calendar, indicating it was scheduled for floor consideration. However, it did not progress further and expired, reflecting either legislative priorities or procedural outcomes during that session.
Hidden impact flags detected: 1
GovScope reviewed 1 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.
['If enacted, the bill could have led to increased funding or programs for cancer screening, potentially affecting healthcare resource allocation.', 'Improved screening could influence cancer detection rates and long-term public health outcomes.', 'Failure to pass may maintain status quo in cancer screening policies and funding.']
The absence of an official summary and full bill text restricts transparency and limits the ability of the public and oversight bodies to fully evaluate the bill's content and implications. The bill's failure to advance beyond the calendar stage suggests limited legislative momentum or competing priorities during the 118th Congress.
GovScope Intelligence Roadmap
Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.